Preoperative -cell function in patients with type 2 diabetes is important for the outcome of Roux-en-Y gastric bypass surgery

被引:28
|
作者
Lund, Michael Taulo [1 ,3 ]
Hansen, Merethe [1 ]
Skaaby, Stinna [1 ]
Dalby, Sina [1 ]
Stockel, Mikael [2 ]
Floyd, Andrea Karen [3 ]
Bech, Karsten [1 ]
Helge, Jorn Wulff [1 ]
Holst, Jens Juul [4 ,5 ]
Dela, Flemming [1 ]
机构
[1] Univ Copenhagen, Dept Biomed Sci, Ctr Healthy Aging, Xlab,Ctr Healthy Aging,Fac Hlth Sci, DK-2200 Copenhagen N, Denmark
[2] Herlev Hosp, Dept Surg, DK-2730 Herlev, Denmark
[3] Koege Hosp, Dept Surg, Koege, Denmark
[4] Univ Copenhagen, NNF Ctr Basic Metab Res, DK-2200 Copenhagen N, Denmark
[5] Univ Copenhagen, Dept Biomed Sci, Fac Hlth Sci, DK-2200 Copenhagen N, Denmark
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2015年 / 593卷 / 14期
关键词
PERIPHERAL INSULIN SENSITIVITY; INTENSIVE MEDICAL THERAPY; BARIATRIC SURGERY; GLUCOSE-TOLERANCE; OBESE-PATIENTS; INCRETIN LEVELS; WEIGHT-LOSS; REMISSION; SECRETION; RESPONSES;
D O I
10.1113/JP270264
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Roux-en-Y gastric bypass surgery leads to remission of type 2 diabetes in the majority of patients suffering from the disease. The gut hormone glucagon-like peptide-1 is believed to be of major importance for the remission process. The present project demonstrates a marked difference in the chance of remission of type 2 diabetes in patients with low or high preoperative -cell function in spite of a similar post-surgery increase in postprandial glucagon-like peptide-1 release. Furthermore, post-surgery intravenous glucose administration, which does not stimulate release of glucagon-like peptide-1, leads to increased insulin secretion in the patients with the best preoperative -cell function. Together the present findings indicate that patients with type 2 diabetes with high preoperative -cell function experience a glucagon-like peptide-1-independent increase in -cell function after gastric bypass surgery. The majority of the patients with type 2 diabetes (T2DM) show remission after Roux-en-Y gastric bypass (RYGB). This is the result of increased postoperative insulin sensitivity and -cell secretion. The aim of the present study was to elucidate the importance of the preoperative -cell function in T2DM for the chance of remission after RYGB. Fifteen patients with and 18 without T2DM had 25g oral (OGTT) and intravenous (IVGTT) glucose tolerance tests performed at inclusion, after a diet-induced weight loss, and 4 and 18months after RYGB. Postoperative first phase insulin secretion rate (ISR) during the IVGTT and -cell glucose sensitivity during the OGTT increased in T2DM. Postoperative insulin sensitivity and the disposition index (DI) markedly increased in both groups. By stratifying the T2DM into two groups according to highest (T2DM(high)) and lowest (T2DM(low)) baseline DI, a restoration of first phase ISR and -cell glucose sensitivity were seen only in T2DM(high). Remission of type 2 diabetes was 71 and 38% in T2DM(high) and T2DM(low), respectively. Postoperative postprandial GLP-1 concentrations increased markedly, but did not differ between the groups. Our findings emphasize the importance of the preoperative of -cell function for remission of diabetes after RYGB.
引用
收藏
页码:3123 / 3133
页数:11
相关论文
共 50 条
  • [1] Surgery for type 2 diabetes: the case for Roux-en-Y gastric bypass
    Spaniolas, Konstantinos
    Pories, Walter J.
    [J]. SURGERY FOR OBESITY AND RELATED DISEASES, 2016, 12 (06) : 1220 - 1224
  • [2] ROUX-EN-Y GASTRIC BYPASS FOR THE REMISSION OF TYPE 2 DIABETES
    Valezi, A. C.
    Marson, A. C.
    Menezes, M. A.
    Sato, R. O.
    Mali Jr, J.
    [J]. OBESITY SURGERY, 2016, 26 : S510 - S511
  • [3] Glycemic variability after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes
    Yin, Tingting
    Bi, Yan
    Zhu, Dalong
    Qian, Yufen
    Zhang, Ningjing
    Miao, Heng
    Feng, Wenhuan
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35
  • [4] Effect of Roux-en-Y gastric bypass on thyroid function in euthyroid patients with obesity and type 2 diabetes
    Liu, Fangyuan
    Di, Jianzhong
    Yu, Haoyong
    Han, Junfeng
    Bao, Yuqian
    Jia, Weiping
    [J]. SURGERY FOR OBESITY AND RELATED DISEASES, 2017, 13 (10) : 1701 - 1707
  • [5] Effects of Roux-en-Y Gastric Bypass on β-Cell Function
    Weiss, Ram
    [J]. DIABETES, 2014, 63 (04) : 1171 - 1173
  • [6] Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study
    Still, Christopher D.
    Wood, G. Craig
    Benotti, Peter
    Petrick, Anthony T.
    Gabrielsen, Jon
    Strodel, William E.
    Ibele, Anna
    Seiler, Jamie
    Irving, Brian A.
    Celaya, Melisa P.
    Blackstone, Robin
    Gerhard, Glenn S.
    Argyropoulos, George
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (01): : 38 - 45
  • [7] Preoperative Factors Predicting Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery for Obesity
    Hall, Tom C.
    Pellen, Mike G. C.
    Sedman, Peter C.
    Jain, Prashant K.
    [J]. OBESITY SURGERY, 2010, 20 (09) : 1245 - 1250
  • [8] Preoperative Factors Predicting Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery for Obesity
    Tom C. Hall
    Mike G. C. Pellen
    Peter C. Sedman
    Prashant K. Jain
    [J]. Obesity Surgery, 2010, 20 : 1245 - 1250
  • [9] Effect of Roux-en-Y Gastric Bypass Surgery on Diabetes Neuropathy
    Le Roux, C.
    Chuah, L.
    Baqai, N.
    Graham, C.
    Nicotra, A.
    Khalil, N.
    Miras, A.
    [J]. OBESITY SURGERY, 2013, 23 (08) : 1115 - 1116
  • [10] Outcomes of Roux-en-Y Gastric Bypass Surgery for Severely Obese Patients with Type 1 Diabetes
    Mendez, Carlos E.
    Tanenberg, Robert J.
    Pories, Walter
    [J]. DIABETES, 2010, 59 : A493 - A494